458 related articles for article (PubMed ID: 18538888)
1. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.
Liu S
Adv Drug Deliv Rev; 2008 Sep; 60(12):1347-70. PubMed ID: 18538888
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc and (111)In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry.
Chakraborty S; Liu S
Curr Top Med Chem; 2010; 10(11):1113-34. PubMed ID: 20388113
[TBL] [Abstract][Full Text] [Related]
3. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Chem Rev; 2010 May; 110(5):2858-902. PubMed ID: 20415480
[No Abstract] [Full Text] [Related]
4. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.
Wilbur DS
Curr Radiopharm; 2011 Jul; 4(3):214-47. PubMed ID: 22201710
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic radiolabeling of biomolecules with PET radiometals.
Zeng D; Desai AV; Ranganathan D; Wheeler TD; Kenis PJ; Reichert DE
Nucl Med Biol; 2013 Jan; 40(1):42-51. PubMed ID: 23078875
[TBL] [Abstract][Full Text] [Related]
6. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
[TBL] [Abstract][Full Text] [Related]
7. Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates.
Gansow OA
Int J Rad Appl Instrum B; 1991; 18(4):369-81. PubMed ID: 1864725
[TBL] [Abstract][Full Text] [Related]
8. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
10. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Bailey GA; Price EW; Zeglis BM; Ferreira CL; Boros E; Lacasse MJ; Patrick BO; Lewis JS; Adam MJ; Orvig C
Inorg Chem; 2012 Nov; 51(22):12575-89. PubMed ID: 23106422
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
Sosabowski JK; Mather SJ
Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332
[TBL] [Abstract][Full Text] [Related]
12. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.
Cai Z; Anderson CJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474
[TBL] [Abstract][Full Text] [Related]
13. Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.
Li M; Meares CF; Zhong GR; Miers L; Xiong CY; DeNardo SJ
Bioconjug Chem; 1994; 5(2):101-4. PubMed ID: 8031871
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals.
Burke BP; Clemente GS; Archibald SJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):239-43. PubMed ID: 24497011
[TBL] [Abstract][Full Text] [Related]
15. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
Blower PJ; Lewis JS; Zweit J
Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
[TBL] [Abstract][Full Text] [Related]
16. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
[TBL] [Abstract][Full Text] [Related]
17. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
[TBL] [Abstract][Full Text] [Related]
18. Enantiopure bifunctional chelators for copper radiopharmaceuticals--does chirality matter in radiotracer design?
Singh AN; Dakanali M; Hao G; Ramezani S; Kumar A; Sun X
Eur J Med Chem; 2014 Jun; 80():308-15. PubMed ID: 24793881
[TBL] [Abstract][Full Text] [Related]
19. Radiometallic Complexes of DO3A-Benzothiazole Aniline for Nuclear Medicine Theranostics.
Park JA; Lee JW; Kim HK; Shin UC; Lee KC; Kim TJ; Chang Y; Kim KM; Kim JY; Lee YJ
Mol Pharm; 2018 Mar; 15(3):1133-1141. PubMed ID: 29381860
[TBL] [Abstract][Full Text] [Related]
20. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.
Holik HA; Ibrahim FM; Elaine AA; Putra BD; Achmad A; Kartamihardja AHS
Molecules; 2022 May; 27(10):. PubMed ID: 35630536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
